MENU
AARD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aardvark Therapeutics (AARD) Earnings Date & Reports
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases... Show more
A.I. Advisor
published Earnings
AARD is expected to report earnings to rise 4.55% to -68 cents per share on November 12
Q3'26
Est.
$-0.69
Q2'26
Beat
by $0.21
Q1'26
Missed
by $0.22
Q4'25
Missed
by $0.01
Q3'25
Beat
by $0.02
The last earnings report on August 11 showed earnings per share of -66 cents, beating the estimate of -87 cents. With 27.29K shares outstanding, the current market capitalization sits at 86.45M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
4370 La Jolla Village Drive
Phone
+1 858 225-7696
Employees
40
Web
https://www.aardvarktherapeutics.com